ERBB2 and maternal uniparental disomy of chromosome 20: Genomic features of HRD were found to be significantly more prevalent in MBCs than in UCSs, whereas known therapeutic targets, such as HER2 gene amplification and FBXW7 mutations, were found to be significantly more frequent in UCSs than MBCs.